Superworth

Shoulder Innovations EPS SI

Diluted earnings per share by quarter and over the last twelve months, from 2024.

Last 12 months, to Jun 30, 2026
−$1.92
Latest quarter, Q2 FY26
−$0.49
Fiscal year 2025
−$218.68

Shoulder Innovations' earnings per share was −$1.92 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.49.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$218.68n/a
FY2024−$249.02n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.49n/a−$1.92
Q1 FY26−$0.41n/a−$166.96
Q4 FY25−$0.38n/a−$218.68
Q3 FY25−$0.64n/a−$263.50
Q2 FY25−$165.53n/a−$331.17
Q1 FY25−$52.13n/a−$238.38
Q4 FY24−$45.20n/a−$249.02
Q3 FY24−$68.31n/an/a
Q2 FY24−$72.74n/an/a
Q1 FY24−$62.77n/an/a

Against its peers

Companies in Medical - Instruments & Supplies nearest Shoulder Innovations' size, closest first, today.

CompanyEPS, 12 monthsGrowth
SIShoulder Innovations−$1.92
EMBCEmbecta$1.47+3% a year
TCMDTactile Systems Technology$1.08+74% a year
MDXGMimedx$0.04−81% a year
INFUInfuSystem$0.41+78% a year
MOVMovado$1.80+137% a year
UTMDUtah Medical Products$3.28−12% a year
PDEXPro DEX$4.11+52% a year
IRMDIradimed$1.79+10% a year
STAAStaar Surgical$0.07
BVSBioventus$0.77
Peer median$1.27

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Shoulder Innovations

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.